Elon Musk has said ending tax credits of up to $7,500 for electric vehicle purchases would "devastate" Tesla's competitors.

Wedbush analyst David Nierengarten maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) today and set a price target of ...

Rights Nov 19, 2007 Nov 26, 2007 Feb 12, 2007 Rights ratio: 1 share for every 1 held at a price of Rs 250.0 Bonus Nov 29, 2004 Nov 30, 2004 Jun 07, 2004 Bonus Ratio: 2 share(s) for every 1 shares held ...